Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Debt Ratio (2016 - 2023)

Amicus Therapeutics' Debt Ratio history spans 14 years, with the latest figure at 0.02 for Q2 2023.

  • For the quarter ending Q2 2023, Debt Ratio fell 25.98% year-over-year to 0.02, compared with a TTM value of 0.02 through Jun 2023, down 25.98%, and an annual FY2022 reading of 0.03, up 41.64% over the prior year.
  • Debt Ratio for Q2 2023 was 0.02 at Amicus Therapeutics, down from 0.02 in the prior quarter.
  • The five-year high for Debt Ratio was 0.21 in Q2 2020, with the low at 0.01 in Q4 2020.
  • Average Debt Ratio over 5 years is 0.08, with a median of 0.03 recorded in 2021.
  • Year-over-year, Debt Ratio skyrocketed 1437.67% in 2019 and then plummeted 94.21% in 2020.
  • Tracing FOLD's Debt Ratio over 5 years: stood at 0.17 in 2019, then plummeted by 94.21% to 0.01 in 2020, then skyrocketed by 107.99% to 0.02 in 2021, then soared by 41.64% to 0.03 in 2022, then crashed by 39.77% to 0.02 in 2023.
  • Per Business Quant, the three most recent readings for FOLD's Debt Ratio are 0.02 (Q2 2023), 0.02 (Q1 2023), and 0.03 (Q4 2022).